← Leaderboards
Karen Joy Shaw
Amplyx Pharmaceuticals, Inc.
$4,769,794
Attributed
$6,583,714
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2015–21$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$6,583,714 · 5
By mechanism
R44$4,431,667 · 4
R01$2,152,047 · 1
Top collaborators
- Marc Sharp3 shared
- William J Steinbach2 shared
Most similar at Amplyx Pharmaceuticals, Inc.
Same institution · by research overlap
- Mitchell W Mutz$6,956,651
Others in their field
Top investigators on “Inhibitor/Antagonist”
- John M Lachin · George Washington University$117,867,649
- David M Nathan · Massachusetts Institute Of Technology$117,867,649
- Randall J Bateman · Washington University$110,978,751
- David Heimbrook · Leidos Biomedical Research, Inc.$72,139,282
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Walter John Curran · Thomas Jefferson University$32,790,605
Research focus
Inhibitor/AntagonistMaximum Tolerated DoseInfectionAntifungal AgentsIn VitroAnalogResistanceMouse ModelCytotoxicityToxic EffectFungusMycosesIn VivoNovel TherapeuticsMortalityCell WallProteinsEnzymesOralAmphotericin BPathogenLifeGpi Membrane AnchorsCytochrome P450
Grant awards (9)
Development of a new class of antifungals effective against Cryptococcus$714,554
R01 · FY2021 · AI
Development of a new class of antifungals effective against Cryptococcus$718,597
R01 · FY2020 · AI
Development of a new class of antifungals effective against Cryptococcus$718,896
R01 · FY2019 · AI
Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections$725,501
R44 · FY2018 · AI · contact PI
Developing a novel antifungal targeting Gwt1 for the treatment of invasive aspergillosis and rare mold infections$750,293
R44 · FY2017 · AI · contact PI
Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis$732,374
R44 · FY2017 · AI · contact PI
Developing a New Therapeutic for the Treatment of Invasive Aspergillosis$745,405
R44 · FY2016 · AI · contact PI
Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis$728,595
R44 · FY2016 · AI · contact PI
A Computer Modeling Approach$749,499
R44 · FY2015 · NS · contact PI